Education
About Us
Working with TipRanks
Follow Us
Mustang Bio Inc (MBIO)
NASDAQ:MBIO
MBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.15 - $65.01
Previous CloseN/A
Volume2.68M
Average Volume (3M)60.62K
Market Cap
$4.07M
Enterprise Value$2.91M
Total Cash (Recent Filing)$75.01M
Total Debt (Recent Filing)$28.00K
Price to Earnings (P/E)―
Beta1.56
Next Earnings
May 09, 2025EPS Estimate
-5.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-43.66
Shares Outstanding2,460,240
10 Day Avg. Volume38,607
30 Day Avg. Volume60,616
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.72
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Mustang Bio News
PremiumCompany Announcements
Mustang Bio Sells Assets to AbbVie, Transfers Lease
---
Ownership Overview
11.31% Insiders
0.51% Mutual Funds
0.17% Other Institutional Investors
88.11% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
MBIO FAQ
What was Mustang Bio Inc’s price range in the past 12 months?
Mustang Bio Inc lowest stock price was $1.15 and its highest was $65.01 in the past 12 months.
What is Mustang Bio Inc’s market cap?
Mustang Bio Inc’s market cap is $4.07M.
When is Mustang Bio Inc’s upcoming earnings report date?
Mustang Bio Inc’s upcoming earnings report date is May 09, 2025 which is in 16 days.
How were Mustang Bio Inc’s earnings last quarter?
Mustang Bio Inc released its earnings results on Mar 24, 2025. The company reported -$0.95 earnings per share for the quarter, beating the consensus estimate of -$5.5 by $4.55.
Is Mustang Bio Inc overvalued?
According to Wall Street analysts Mustang Bio Inc’s price is currently Overvalued.
Does Mustang Bio Inc pay dividends?
Mustang Bio Inc does not currently pay dividends.
What is Mustang Bio Inc’s EPS estimate?
Mustang Bio Inc’s EPS estimate is -5.5.
How many shares outstanding does Mustang Bio Inc have?
Mustang Bio Inc has 2,460,240 shares outstanding.
What happened to Mustang Bio Inc’s price movement after its last earnings report?
Mustang Bio Inc reported an EPS of -$0.95 in its last earnings report, beating expectations of -$5.5. Following the earnings report the stock price went up 0.714%.
Which hedge fund is a major shareholder of Mustang Bio Inc?
Currently, no hedge funds are holding shares in MBIO
---
Company Description
Mustang Bio Inc
Mustang Bio, Inc. (MBIO) is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of cancer and rare genetic diseases. The company's primary focus lies in advancing its gene and cell therapy platforms, which are designed to harness the power of the patient's immune system to target and eliminate diseased cells. Mustang Bio is involved in both clinical and preclinical development stages, working on a pipeline of promising therapeutic candidates.
---
MBIO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering MBIO
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-87.13%
reiterated a buy rating 11 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -87.13% per trade.
---